Studying Family Links and Genetics in Thyroid Cancer for Better Screening
NCT01109420 · RecruitingThis study looks at thyroid cancer that appears in families. Most thyroid cancers are non-medullary, but researchers want to learn more about the genes that may cause it. The goal is to find better ways to screen for this type of cancer so it can be caught and treated early. They want to understand how it develops, the best ways to find it, and identify genes that may make someone more likely to get it.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- National Institutes of Health Clinical CenterBethesda, MarylandRecruiting
Who can join
This study is for individuals aged 7 to 90 years old, both males and females. To join, you must have two family members with non-medullary thyroid cancer or one family member with a diagnosis of the cancer. You can also join if you are a family member of someone with this condition. The trial team will confirm who is eligible.
What happens during the trial
Participants will be grouped based on their connection to non-medullary thyroid cancer. Group 1 includes those with the cancer, and Group 2 includes family members without the cancer. Everyone will be checked through family history, physical exams, imaging tests, and may provide blood samples. Those without cancer will be checked yearly, while others will learn about treatment options if cancer is found.
The trial team
The trial is led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Joanna Klubo-Gwiezdzinska is the principal investigator overseeing the study.
Important dates
The study started on August 12, 2010, and is currently recruiting participants. It is expected to finish by June 18, 2026.
Additional information
The trial's ID number is NCT01109420. This is an observational study, meaning researchers will watch and gather information without giving treatments. It is not an FDA-regulated drug or device trial, and they hope to include about 500 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →